SGFG
ZYME icon

Silver Grove Financial Group’s Zymeworks ZYME Stock Holding History

Silver Grove Financial Group’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105 Buy
+4
New +$102 ﹤0.01% 2329

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Silver Grove Financial Group's ZYME Position: Q2 2026 in Review

Silver Grove Financial Group opened a new position in Zymeworks (ZYME) in Q2 2026: 4 shares worth $105. The stake represents ﹤0.01% of the portfolio and ranks #2329 among its holdings.

202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Silver Grove Financial Group held 4 shares of Zymeworks worth $105 as of Q2 2026.
  • Zymeworks was a new Silver Grove Financial Group position in Q2 2026.
  • Zymeworks made up ﹤0.01% of Silver Grove Financial Group's portfolio in Q2 2026, its #2329 holding.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.